Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:17 pm Sale | 13G | iSpecimen Inc. ISPC | OBF Investments LLC | 845,231 9.300% | -6,638 (-0.78%) | View |
2023-04-17 1:27 pm Purchase | 13D | iSpecimen Inc. ISPC | Ross Andrew L. | 1,336,730 14.797% | 6,971 (+0.52%) | View |
2023-02-13 4:04 pm Purchase | 13G | iSpecimen Inc. ISPC | OBF Investments LLC | 851,869 9.500% | 8,638 (+1.02%) | View |
2023-01-12 10:01 am Sale | 13G | iSpecimen Inc. ISPC | Empery Asset Management LP | 437,500 4.680% | -28,833 (-6.18%) | View |
2022-12-27 1:31 pm Purchase | 13G | iSpecimen Inc. ISPC | Wolf James G. | 790,730 9.030% | 246,480 (+45.29%) | View |
2022-09-27 9:34 pm Purchase | 13G | iSpecimen Inc. ISPC | Wolf James G. | 544,250 6.130% | 544,250 (New Position) | View |
2022-02-14 4:36 pm Purchase | 13G | iSpecimen Inc. ISPC | OBF Investments LLC | 843,231 9.700% | 843,231 (New Position) | View |
2022-02-14 4:03 pm Sale | 13G | iSpecimen Inc. ISPC | Bleichroeder LP | 342,180 3.410% | -276,000 (-44.65%) | View |
2022-02-07 10:30 am Purchase | 13G | iSpecimen Inc. ISPC | Ross Andrew L. | 1,329,759 15.230% | 1,329,759 (New Position) | View |
2022-01-24 10:32 am Purchase | 13G | iSpecimen Inc. ISPC | Empery Asset Management LP | 466,333 5.340% | 466,333 (New Position) | View |
2021-07-08 5:34 pm Purchase | 13G | iSpecimen Inc. ISPC | Bleichroeder LP | 618,180 9.500% | 618,180 (New Position) | View |